|
COPG2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.65112368222253E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.69875224997895E-12 |
| Normal-vs-Stage2 |
2.674300E-02 |
| Normal-vs-Stage3 |
9.061900E-03 |
| Normal-vs-Stage4 |
8.202100E-02 |
| Stage1-vs-Stage2 |
5.786000E-01 |
| Stage1-vs-Stage3 |
3.955800E-02 |
| Stage1-vs-Stage4 |
4.674600E-01 |
| Stage2-vs-Stage3 |
2.147200E-01 |
| Stage2-vs-Stage4 |
4.244400E-01 |
| Stage3-vs-Stage4 |
6.293800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.48769885299771E-14 |
| Normal-vs-AfricanAmerican |
1.022350E-04 |
| Normal-vs-Asian |
2.402200E-02 |
| Caucasian-vs-AfricanAmerican |
5.001600E-01 |
| Caucasian-vs-Asian |
6.451800E-01 |
| AfricanAmerican-vs-Asian |
5.798600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.91344726122134E-12 |
| Normal-vs-Female |
3.8083000086786E-09 |
| Male-vs-Female |
9.968000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.62340000001249E-06 |
| Normal-vs-Extreme_Weight |
2.00389704829718E-11 |
| Normal-vs-Obese |
4.248699999998E-05 |
| Normal-vs-Extreme_Obese |
2.184900E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.205400E-01 |
| Normal_Weight-vs-Obese |
9.259600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.766400E-01 |
| Extreme_Weight-vs-Obese |
4.020200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.587400E-01 |
| Obese-vs-Extreme_Obese |
9.090200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.845050E-04 |
| Normal-vs-Age(41-60Yrs) |
3.31701333067258E-12 |
| Normal-vs-Age(61-80Yrs) |
8.80669981384585E-11 |
| Normal-vs-Age(81-100Yrs) |
7.154200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.672600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.482600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.030400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.671400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.417200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.094400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
1.523230E-03 |
| Normal-VS-KIRP CIMP |
3.715600E-02 |
| Normal-VS-Unclassified PRCC |
3.97500000000051E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.94899999472753E-08 |
| Type1 PRCC-VS-KIRP CIMP |
5.68699999999867E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.590250E-04 |
| Type2 PRCC-VS-KIRP CIMP |
6.534000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.175800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.184600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.817500E-04 |
| Normal-vs-N1 |
6.603600E-03 |
| Normal-vs-N2 |
1.882730E-03 |
| N0-vs-N1 |
9.732200E-01 |
| N0-vs-N2 |
4.458400E-01 |
| N1-vs-N2 |
4.767600E-01 |
|
|
